Prof. Mark Bellgrove
President. BSc (Hons), PhD
Professor Bellgrove has studied the neurobiology of ADHD for over 15 years and is internationally known for his work on the genetics, neuropsychology and pharmacology of ADHD. His research achievements have been recognized with awards from NARSAD (USA), the Academy of Social Sciences in Australia and Biological Psychiatry Australia.
Professor Bellgrove is a strong advocate for evidenced-based diagnosis, treatment and management of ADHD and has a strong vision for the development of unified national diagnosis, prescribing and treatment practices and AADPA’s role in influencing policy to ensure a “better deal” for the many individuals affected by ADHD within Australia.
Disclosure
Prof. Bellgrove has in the past received a research grant from Eli Lily. He has received grants related to ADHD from the Science Foundation Ireland, the Irish Health Research Board, the National Health and Medical Research Council (NHMRC) Australia, the Murdoch Children’s Research Institute (Australia), National Alliance on Schizophrenia and Allied Disciplines (NARSAD) – US, and the Australian Research Council. He has received an educational grant from Shire. He has given educational talks at meetings sponsored by Janssen-Cilag, Eli Lilly and Shire. Prof. Bellgrove is a founding member and inaugural President of the Australian ADHD Professionals Association.
Prof. David Coghill
Vice-President.
David Coghill is committed to the development and implementation of evidence-based pathways for ADHD and has been involved in the development of several National and International Clinical guidelines for ADHD.
David’s research interests include neuroscience, neuropsychology, Neuropsychopharmacology, health services research, implementation science, clinical trials, pharmacovigilance and quality of life. He is the chair of EUNETHYDIS International conferences, a charity that supports education and research in ADHD and related disorders and is a longstanding member of the executive committee of the European Network for Hyperkinetic Disorders (EUNETHYDIS).
Disclosure
Prof. Coghill has received research support from Shire and Vifor Pharma. He has also received research grants related to ADHD from the EU, the National Institute for Health Research (NIHR) UK, National Health and Medical Research Council (NHMRC) Australia, the Murdoch Children’s Research Institute (Australia), Department of Health (UK). He has received honoraria for advisory boards/speaking from Shire, Eli Lilly, Janssen-Cilag, Medice, Novartis. He receives royalties from Oxford University Press. Prof. Coghill is a founding member and inaugural Vice-President of the Australian ADHD Professionals Association Ltd.
Dr Roger Paterson
Committee Member.
Roger Paterson, MB BS, FRCPsych, FRANZCP, Cert. Child & Adol. Psych, has been active in the field of child, adolescent and adult ADHD for many years. In the public sector from 1989 to 1996 in child psychiatry, and in full-time general child and adult private practice thereafter, with the last few years being mostly an ADHD practice across the lifespan.
Disclosure
Recipient of Speaker’s fee received from Janssen, Eli Lilly, Novartis, Shire and Servier. Advisory Board paid member: Eli Lilly and Shire. Conference sponsorship: Astra-Zeneca, Janssen-Cilag, Lilly, Novartis, Pfizer, Shire and Solvay.
Dr Michele Toner
Committee Member.
Dr Toner works in private practice as a specialist ADHD coach. Trained as a teacher, she developed a special interest in students who learn differently, which ultimately led her to ADHD coaching. She has spent 20 years’ in ADHD Advocacy on a state and national level and has strong connections to community, academic and professional networks.
Michele worked with others to form the national consumer advocacy group ADHD Australia and was a member of their inaugural board. Michele is committed to evidence-based approaches, coaching adults, adolescents and children. Michele also trains coaches as a faculty member of the ADD Coach Academy in New York and is a registered mentor coach.
Disclosure
Dr Toner has given educational talks and attended meetings sponsored by Janssen-Cilag, Eli Lilly, Novartis and Shire. She has reviewed educational materials for Shire. She receives royalties from UWA Press. She receives payment from schools and universities for PD talks and student coaching.
Prof. Christel Middeldorp
Committee Member.
Professor Middeldorp’s research focuses on the role of genetic and other familial factors in the development and persistence of common psychiatric symptoms in childhood, including ADHD. She also investigates the role of parental mental health problems, on the outcome of psychiatric symptoms in a clinical cohort and will perform a trial to study whether addressing parental mental health also improves the outcome for the children.
Professor Middeldorp is committed to facilitating patient advocacy, increasing stakeholder representation and establishing an essential large network to investigate ADHD on the large scale that is necessary to identify biomarkers. She also aims to translate the knowledge from the fundamental and clinical research via her contribution to the design of clinical guidelines.
Dr Emma Sciberras
Committee Member.
Dr Sciberras has worked in the area of ADHD for 13 years and has been recognised by the Australian Institute for Policy and Science for her achievements. She holds a National Health & Medical Research Council Career Development Fellowship focused on the development of evidence-based behavioural interventions to improve outcomes for young people with ADHD.
Dr Sciberras is committed to reducing the stigma associated with ADHD and disseminating evidence-based information about the disorder to the general community. Her strong track record in ADHD research (>80 publications, ~$7M in research funding) will be invaluable in advocating for funding for the organisation and supporting AADPA’s activities more broadly.
Disclosure
Dr Sciberras has received grants related to ADHD from the National Health and Medical Research Council (NHMRC) Australia, the Murdoch Children’s Research Institute (Australia) and Deakin University.
Dr Paul Hutchins
Committee Member.
Dr Paul Hutchins, AM MA BM BCh (Oxon) FRACP MRCPCH MRCP DCH, Dr Hutchins is a Senior Paediatric Consultant to The Children’s Hospital Education Research Institute, which he helped establish, an Honorary Medical Officer at the Children’s Hospital, Westmead and an Honorary Associate at Sydney Medical School, University of Sydney.
Dr Hutchins has over 35 years of tertiary developmental practice and collaboration with educators, parents, support groups and health professionals. He has contributed to Australia and internationally to guidelines for ADHD management and chaired the Stimulant Subcommittee NSW for nearly 20 years. He is committed to comprehensive collaborative and evidence-based support and promoting links between AADPA and other professionals’ expertise, activities, research and resources, particularly paediatricians and NBPSA, Allied Health and Education.
Disclosure
Recipient of honoraria for research, advisory boards / speaking from Celltech, Janssen-Cilag, Eli Lilly, Novartis and Shire. I am a life member of Neurodevelopental Behavioural Paediatric Society of Australasia and of the Learning Difficulty Coalition. I am a member of Advisory Board of the Neurodevelopment and Special Education Forum UK. I was awarded the Medal of the Order of Australia for my contributions to the interdisciplinary care of complex developmental disorders for children and families.
